The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic Steatohepatitis
Trial details
- Registry ID
- NCT04134091
- Phase
- Phase 2
Drug identity checked against registry records
Also recorded as testosterone undecanoate with d-alpha tocopherol
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| The Efficacy, Safety and Tolerability of Oral LPCN 1144 in Subjects With Nonalcoholic SteatohepatitisNCT04134091 | LPCN | Phase 2 | Completed | 2021-06-24Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |